Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Infertility × follitropin beta × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Infertility, Female 1 Infertility 1

Interventions

Letrozole 3 follitropin alfa 2 Goserelin 2 Cyclophosphamide 2 Clomiphene 2 follitropin beta 1 cetrorelix 1 Urofollitropin 1 Triptorelin Pamoate 1 Thioctic Acid 1 Therapeutics 1 Tamoxifen 1 Surgical Procedures, Operative 1 Sperm Injections, Intracytoplasmic 1 Neoadjuvant Therapy 1 Metformin 1 Congresses as Topic 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01081639 2014-07-31

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Merck KGaA, Darmstadt, Germany

Phase 3 Completed

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡